ArticleOncotarget2017
TRIB2 contributes to cisplatin resistance in small cell lung cancer.
Yuanxin Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncotarget2017
Yuanxin Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.